Literature DB >> 7518101

Charcot-Marie-Tooth disease: a new paradigm for the mechanism of inherited disease.

P I Patel1, J R Lupski.   

Abstract

Recent work has identified the genes and mutational mechanisms that underlie several inherited diseases of the peripheral nervous system and has provided both the first genetic rationale for classification of these disorders and an insight into their biological basis. These studies have yielded some surprising findings, including the discovery that two very different mutational mechanisms (duplication and point mutation) can result in a similar clinical phenotype in Charcot-Marie-Tooth disease type 1A, and that mutations involving the same gene can give rise to different clinical phenotypes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7518101     DOI: 10.1016/0168-9525(94)90214-3

Source DB:  PubMed          Journal:  Trends Genet        ISSN: 0168-9525            Impact factor:   11.639


  31 in total

1.  2002 Curt Stern Award Address. Genomic disorders recombination-based disease resulting from genomic architecture.

Authors:  James R Lupski
Journal:  Am J Hum Genet       Date:  2003-02       Impact factor: 11.025

2.  HNMP-1: a novel hematopoietic and neural membrane protein differentially regulated in neural development and injury.

Authors:  L M Bolin; T McNeil; L A Lucian; B DeVaux; K Franz-Bacon; D M Gorman; S Zurawski; R Murray; T K McClanahan
Journal:  J Neurosci       Date:  1997-07-15       Impact factor: 6.167

Review 3.  Genetic aspects of Charcot-Marie-Tooth disease.

Authors:  C Bell; N Haites
Journal:  Arch Dis Child       Date:  1998-04       Impact factor: 3.791

4.  How is the Human Genome Project doing, and what have we learned so far?

Authors:  M S Guyer; F S Collins
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

5.  Connexin 32 mutations from X-linked Charcot-Marie-Tooth disease patients: functional defects and dominant negative effects.

Authors:  Y Omori; M Mesnil; H Yamasaki
Journal:  Mol Biol Cell       Date:  1996-06       Impact factor: 4.138

6.  Peripheral neuropathy in mice transgenic for a human MDR3 P-glycoprotein mini-gene.

Authors:  J J Smit; F Baas; J E Hoogendijk; G H Jansen; M A van der Valk; A H Schinkel; A J Berns; D Acton; K Nooter; H Burger; S J Smith; P Borst
Journal:  J Neurosci       Date:  1996-10-15       Impact factor: 6.167

7.  A family segregating a Friedreich ataxia phenotype that is not linked to the FRDA locus.

Authors:  P Smeyers; E Monrós; J Vílchez; J Lopez-Arlandis; F Prieto; F Palau
Journal:  Hum Genet       Date:  1996-06       Impact factor: 4.132

8.  Isolation of a cosmid clone corresponding to an inv(21) breakpoint of a patient with transient abnormal myelopoiesis.

Authors:  T Ohta; M Nakano; T Tsujita; K Abe; K Osoegawa; T Yamagata; K Yoshiura; Y Jinno; E Soeda; Y Nakamura; N Niikawa
Journal:  Am J Hum Genet       Date:  1996-03       Impact factor: 11.025

Review 9.  Molecular anatomy and genetics of myelin proteins in the peripheral nervous system.

Authors:  G J Snipes; U Suter
Journal:  J Anat       Date:  1995-06       Impact factor: 2.610

10.  Disorders of the genome architecture: a review.

Authors:  Dhavendra Kumar
Journal:  Genomic Med       Date:  2009-03-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.